ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 632 filers reported holding ASTRAZENECA PLC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,678 | -22.4% | 5,872 | -37.9% | 0.02% | +63.6% |
| Q2 2023 | $512,419 | +167.2% | 9,456 | +81.5% | 0.01% | +37.5% |
| Q1 2023 | $191,747 | +36284.6% | 5,209 | -62.5% | 0.01% | -42.9% |
| Q4 2022 | $527 | -99.9% | 13,904 | +41.3% | 0.01% | +40.0% |
| Q3 2022 | $381,000 | +24.1% | 9,838 | +23.6% | 0.01% | 0.0% |
| Q2 2022 | $307,000 | -27.3% | 7,962 | -28.3% | 0.01% | +100.0% |
| Q1 2022 | $422,000 | +141.1% | 11,098 | +275.1% | 0.01% | +66.7% |
| Q4 2021 | $175,000 | -6.4% | 2,959 | -4.3% | 0.00% | -25.0% |
| Q3 2021 | $187,000 | -16.1% | 3,092 | -16.4% | 0.00% | -20.0% |
| Q2 2021 | $223,000 | -14.6% | 3,697 | -29.7% | 0.01% | 0.0% |
| Q1 2021 | $261,000 | -24.3% | 5,260 | -24.8% | 0.01% | -64.3% |
| Q4 2020 | $345,000 | -0.9% | 6,996 | +10.5% | 0.01% | -33.3% |
| Q3 2020 | $348,000 | +83.2% | 6,333 | +76.9% | 0.02% | +40.0% |
| Q2 2020 | $190,000 | +36.7% | 3,581 | +8.6% | 0.02% | +7.1% |
| Q1 2020 | $139,000 | -19.2% | 3,296 | -3.9% | 0.01% | +7.7% |
| Q4 2019 | $172,000 | -6.5% | 3,428 | -16.6% | 0.01% | +8.3% |
| Q3 2019 | $184,000 | +240.7% | 4,110 | +201.1% | 0.01% | +71.4% |
| Q1 2019 | $54,000 | -80.5% | 1,365 | -81.4% | 0.01% | -58.8% |
| Q4 2018 | $277,000 | -16.6% | 7,321 | -12.9% | 0.02% | +21.4% |
| Q3 2018 | $332,000 | +12.9% | 8,402 | +0.3% | 0.01% | +16.7% |
| Q2 2018 | $294,000 | -8.1% | 8,380 | -9.3% | 0.01% | -20.0% |
| Q1 2018 | $320,000 | 0.0% | 9,236 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $320,000 | -40.7% | 9,236 | -42.1% | 0.02% | -28.6% |
| Q3 2017 | $540,000 | +8.7% | 15,953 | +9.5% | 0.02% | 0.0% |
| Q2 2017 | $497,000 | +40.8% | 14,570 | +28.5% | 0.02% | +40.0% |
| Q1 2017 | $353,000 | +45.9% | 11,335 | +28.2% | 0.02% | +25.0% |
| Q4 2016 | $242,000 | -58.3% | 8,844 | -50.0% | 0.01% | -60.0% |
| Q3 2016 | $581,000 | +3.2% | 17,685 | -5.2% | 0.03% | -3.2% |
| Q2 2016 | $563,000 | +942.6% | 18,652 | +1266.4% | 0.03% | +342.9% |
| Q1 2016 | $54,000 | -90.4% | 1,365 | -91.8% | 0.01% | -81.6% |
| Q4 2015 | $563,000 | – | 16,576 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |